Nature Clinical Practice Urology
The Evolution of Midurethral Slings CME

Disclosures

Release Date: March 4, 2008; Valid for credit through March 4, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

  1. The Evolution of Midurethral Slings
    David E. Rapp, MD
    Kathleen C. Kobashi, MD

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify the principles of early urethral slings used to address female incontinence
  2. List the sources of material used for urethral slings
  3. Describe principles of maintenance of urinary continence in females
  4. Describe the cure rates associated with midurethral sling placement for stress urinary incontinence
  5. List the most common complications associated with midurethral slings
Authors and Disclosures

David E. Rapp, MD
Disclosure: David E. Rapp, MD, has disclosed no relevant financial relationships.


Kathleen C. Kobashi, MD
Disclosure: Kathleen C. Kobashi, MD, has disclosed a consultant relationship to Coloplast. Dr. Kobashi has also disclosed that she is on the speakers' bureau for Novartis and Astellas.


Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.